Gut microbiota dysbiosis and the gut–lung axis in COPD: mechanisms, clinical relevance, and microbiota-targeted interventions
Yinghui Chai, Junya Lan, Kang Li, Xue Mei, Yanan Chen, Nannan Zhou, Xin Liu, Wenping Gong, Hong Lei · 2026
Read Gut microbiota dysbiosis and the gut–lung axis in COPD: mechanisms, clinical relevance, and microbiota-targeted interventions by Yinghui Chai, Junya Lan, Kang Li, Xue Mei, Yanan Chen, Nannan Zhou, Xin Liu, Wenping Gong, Hong Lei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578636.txt.
Description
Gut germ imbalance and the gut-lung link in chronic lung disease are reviewed by Yinghui Chai and co-authors in work dated 2026. The disease, COPD, blocks airflow and keeps the lungs inflamed. Patients often hold fewer kinds of gut germs and fewer of the types that make helpful short acids. Smoke, low oxygen, drugs, and age all drive that shift.
A weak gut wall lets germ parts leak into blood, which fans lung harm. Germ waste goods, from acids to bile goods, also steer immune replies. Cures in view span fiber, live germs, germ food, stool grafts, and virus tools. Clinic proof is still thin, the team notes.
Catalog record
| CREATOR | Yinghui Chai, Junya Lan, Kang Li, Xue Mei, Yanan Chen, Nannan Zhou, Xin Liu, Wenping Gong, Hong Lei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |